Valeant Pharmaceuticals International Inc $122.05

up +0.60


17/4/2014 06:40 PM  |  NYSE : VRX  
Industries : Drugs / Drug Delivery & Accessories
Get Trend Analysis Icon Get VRX Trend Analysis - it has outperformed the S&P 500 by 47%

Partner Headlines

  1. Facebook, Walgreen Climb Monday On International News

    IBD
  2. Nasdaq Finishes Near 4000 Level In Another Sell-Off

    IBD
  3. Stocks Extend Gains; Trimble Navigation Finds Support

    IBD
  4. Ethical Drug Stocks Are Struggling

    IBD
  5. IBD 50 Stocks Fade With Market; Some Trip Sell Rules

    IBD
  6. Top Guru-Held Canadian Stocks

    GuruFocus
  7. Drug, Airline Stocks Top Shortened Weekly Review

    IBD
  8. Selling Pressure Builds In Leading Growth Stocks, Nasdaq

    IBD
  9. Top Industry Groups Take Big Hits In Market Sell-Off

    IBD
  10. 'We do not rely on Wall Street-generated research' - A Look at Former Buffett ...

    GuruFocus
  11. Biotechs, Medicals Get Hurt Amid Price-Inquiry News

    IBD
  12. Tableau, Vertex, Wynn Setting Up Follow-On Buy Areas

    IBD
  13. Tableau, Vertex, Wynn Setting Up Follow-On Buy Areas

    IBD
  14. Gentherm, Kors Setting Up in Tight Formations

    IBD
  15. Leaders Finding Support As Market Takes A Breather

    IBD
  16. Three Leading Growth Names Pull Back To Key Support Level

    IBD
  17. Valeant Pharmaceuticals Hit By Budget Tax Clause

    IBD
  18. Highflying Drug, Biotech Stocks Take Rare Drubbing

    IBD
  19. Nasdaq Lags As Stock Market Closes Lower

    IBD
  20. Early Gains Fade; E-House Breaks Out But Biotechs Stumble

    IBD
  21. Sequoia Fund Comments on Valeant Pharmaceuticals, Advance Auto Parts, Berkshire ...

    GuruFocus
  22. Sequoia Fund's Discussion of Valeant Pharmaceuticals

    GuruFocus
  23. Stock Market Closes Mixed; Ambarella Tops Expectations

    IBD
  24. Stock Market Closes Mixed; Medical Leaders Drop

    IBD
  25. Drugmakers Actavis, Biogen, Valeant Hold Near Highs

    IBD
  26. Valeant Hits New High On Q4

    IBD
  27. Valeant Beats Q4 Estimates, Talks Buyout Strategy

    IBD
  28. Stocks Regain Footing; Baidu Breaks Out

    IBD
  29. Valeant Q4 Earnings Beat Street; Stock Hits High

    IBD
  30. Stock Futures Slightly Lower; Best Buy, JC Penney Jump Higher

    IBD
  31. UPDATE: Valeant Posts Upbeat Q4 Profit

    Benzinga
  32. Stocks Edge Up; Tesla Announces $1.6 Bil Bond Sale

    IBD
  33. Gilead Builds Rare Ascending Base

    IBD
  34. Valeant, Jazz Among IBD 50 Stocks Earnings This Week

    IBD
  35. Akorn, WuXi PharmaTech Clear Buy Points, Pace IBD 50

    IBD
  36. Akorn, Several Other Leading Stocks Showing Promise

    IBD
  37. Stocks Tack On More Gains; Facebook Cuts Losses

    IBD
  38. Medicals Among Top 20 Groups, Retailers Near Bottom

    IBD
  39. Actavis' Buyout Of Forest Creating Spec Pharma Giant

    IBD
  40. Stocks Mostly Higher In Afternoon; Qihoo Hits New High

    IBD
  41. Broad Stock Indexes Gain; Coke Weighs On Dow

    IBD
  42. Lou Simpson's Top Five Stocks at Year End

    GuruFocus
  43. Akorn Among Several Leading Stocks Working On Bases

    IBD
  44. Two Important Additions For Microsoft

    GuruFocus
  45. Specialty Pharma Gets Bigger

    IBD
  46. Stocks End Week On High Note; Priceline Gaps Above 50-Day

    IBD
  47. Actavis, Valeant, Jazz: New Roles For Specialty Pharma

    IBD
  48. Jazz, Valeant Pace Highly Rated Ethical Drugs Group

    IBD
  49. Stock Futures Lean Into Rebound; Valeant, Michael Kors Rocket

    IBD
  50. ArthroCare Sold For $1.5 Bil

    IBD
Trading Center